Orbimed Advisors - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$854,000
-57.3%
100,0000.0%0.02%
-33.3%
Q3 2018$2,002,000
-22.5%
100,0000.0%0.02%
-22.6%
Q2 2018$2,583,000100,0000.03%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders